
SEC exempt reporting adviser · Early stage · Est. 2014
Fannin
Fannin is a Houston-based life sciences innovation studio that licenses drug and medical-device technologies from academic inventors and develops them using a mix of investor and grant funding.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Fannin right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Fannin joined, from press and the firm’s own posts.
Every round Fannin joined
Round sizes, Fannin’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Fannin backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Fannin
Events where Fannin’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Fannin is based in Houston, United States.
In 2014.
11 fund vehicles are on public registers (SEC adviser filings), including FANNIN PI HOLDINGS VII, LLC, FANNIN PI HOLDINGS VI, LLC and FANNIN PI HOLDINGS VIII, LLC.
Stages: Early stage. Sectors: Life sciences, Biotech, Medtech. From the firm’s own website.
Takes university-originated drug and device technologies and acts as both the operating team and the first investor, working alongside the inventors and tapping grants where suitable. The model targets cities with strong research but little commercialization infrastructure, and aims at serious unmet medical needs. From the firm’s own website.
Fannin lists 3 portfolio companies on its website: PROCYRION, INC., ALLTERUM THERAPEUTICS, INC. and PULMOTECT, INC..
Know before Fannin’s next round is announced.
PRO tracks Fannin’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.